Actively Recruiting
Communication Bridge 3 Study
Led by University of Chicago · Updated on 2025-05-30
200
Participants Needed
1
Research Sites
203 weeks
Total Duration
On this page
Sponsors
U
University of Chicago
Lead Sponsor
W
Western University, Canada
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study will use a randomized controlled trial design to evaluate the effect of two evidence-based treatments for adults with mild-moderate Primary Progressive Aphasia (PPA). The aim of the study is to help us better understand the effects of speech-language therapy on communication abilities in individuals with PPA.
CONDITIONS
Official Title
Communication Bridge 3 Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of Primary Progressive Aphasia confirmed by a neurologist and medical records
- English as the primary language used in daily communication
- Adequate hearing (with or without aids) for communication in crowded environments
- Adequate vision (with or without aids) for reading functional materials
- Ability to pass technology screening and use video conferencing and Communication Bridge™ web application
- Geriatric Depression Scale score of 9 or less
- Mild to moderate PPA confirmed by speech-language pathologist evaluation and standardized testing
- Communication partner aged 18 or older
- Communication partner uses English as primary language
- Communication partner has adequate hearing for communication in crowded environments
- Communication partner can pass technology screening and use required applications
You will not qualify if you...
- Diagnosis of dementia other than Primary Progressive Aphasia
- Concurrent participation in an outside speech language therapy program during the study
- Communication partners with pre-existing communication impairments such as aphasia or dementia that would affect participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Chicago - American School Building
Chicago, Illinois, United States, 60637
Actively Recruiting
Research Team
M
Matthew Bona, MPH
CONTACT
E
Emily Cummings
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here